| Diagnosis and management of leukocytoclastic vasculitis P Fraticelli, D Benfaremo, A Gabrielli Internal and emergency medicine 16 (4), 831-841, 2021 | 150 | 2021 |
| Abnormal liver function tests predict transfer to intensive care unit and death in COVID‐19 S Piano, A Dalbeni, E Vettore, D Benfaremo, M Mattioli, CG Gambino, ... Liver International 40 (10), 2394-2406, 2020 | 144 | 2020 |
| Musculoskeletal and rheumatic diseases induced by immune checkpoint inhibitors: a review of the literature D Benfaremo, L Manfredi, MM Luchetti, A Gabrielli Current drug safety 13 (3), 150-164, 2018 | 89 | 2018 |
| Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic MM Luchetti, D Benfaremo, A Campanati, E Molinelli, M Ciferri, S Cataldi, ... Clinical rheumatology 37, 2741-2749, 2018 | 61 | 2018 |
| Safety of intermediate dose of low molecular weight heparin in COVID-19 patients M Mattioli, D Benfaremo, M Mancini, L Mucci, P Mainqua, A Polenta, ... Journal of thrombosis and thrombolysis 51, 286-292, 2021 | 57 | 2021 |
| Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study VK Jaeger, M Tikly, D Xu, E Siegert, E Hachulla, P Airò, G Valentini, ... Rheumatology 59 (7), 1684-1694, 2020 | 56 | 2020 |
| The DETection of Arthritis in Inflammatory boweL diseases (DETAIL) questionnaire: development and preliminary testing of a new tool to screen patients with inflammatory bowel … M Di Carlo, MM Luchetti, D Benfaremo, E Di Donato, P Mosca, S Maltoni, ... Clinical rheumatology 37, 1037-1044, 2018 | 51 | 2018 |
| Biologics in inflammatory and immunomediated arthritis MM Luchetti, D Benfaremo, A Gabrielli Current pharmaceutical biotechnology 18 (12), 989-1007, 2017 | 42 | 2017 |
| A validation study of the Simple Psoriatic Arthritis Screening (SiPAS) questionnaire to screen psoriasis patients for psoriatic arthritis F Salaffi, M Di Carlo, MM Luchetti, E Di Donato, A Campanati, ... Clin Exp Rheumatol 36 (1), 127-35, 2018 | 37 | 2018 |
| Systemic sclerosis: from pathophysiology to novel therapeutic approaches D Benfaremo, S Svegliati, C Paolini, S Agarbati, G Moroncini Biomedicines 10 (1), 163, 2022 | 36 | 2022 |
| Is there a future for anti-CD38 antibody therapy in systemic autoimmune diseases? D Benfaremo, A Gabrielli Cells 9 (1), 77, 2020 | 32 | 2020 |
| Certolizumab pegol for the treatment of psoriasis A Campanati, D Benfaremo, MM Luchetti, G Ganzetti, A Gabrielli, ... Expert opinion on biological therapy 17 (3), 387-394, 2017 | 31 | 2017 |
| Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease–associated spondyloarthritis MM Luchetti, F Ciccia, C Avellini, D Benfaremo, A Rizzo, T Spadoni, ... Rheumatology 60 (1), 92-102, 2021 | 29 | 2021 |
| Sclerostin and antisclerostin antibody serum levels predict the presence of axial spondyloarthritis in patients with inflammatory bowel disease MM Luchetti, F Ciccia, C Avellini, D Benfaremo, G Guggino, A Farinelli, ... The Journal of rheumatology 45 (5), 630-637, 2018 | 29 | 2018 |
| PDGF/PDGFR: a possible molecular target in scleroderma fibrosis C Paolini, S Agarbati, D Benfaremo, M Mozzicafreddo, S Svegliati, ... International Journal of Molecular Sciences 23 (7), 3904, 2022 | 28 | 2022 |
| Biologics in inflammatory immune-mediated systemic diseases G Moroncini, G Calogera, D Benfaremo, A Gabrielli Current Pharmaceutical Biotechnology 18 (12), 1008-1016, 2017 | 27 | 2017 |
| Current take on systemic sclerosis patients’ vaccination recommendations G Murdaca, G Noberasco, D Olobardi, C Lunardi, M Maule, L Delfino, ... Vaccines 9 (12), 1426, 2021 | 26 | 2021 |
| New insights in physical therapy and rehabilitation in psoriatic arthritis: a review FM Perrotta, S Scriffignano, D Benfaremo, M Ronga, MM Luchetti, ... Rheumatology and Therapy 8, 639-649, 2021 | 26 | 2021 |
| The neuropathic pain features in psoriatic arthritis: a cross-sectional evaluation of prevalence and associated factors M Di Carlo, P Muto, D Benfaremo, MM Luchetti, F Atzeni, F Salaffi The Journal of rheumatology 47 (8), 1198-1203, 2020 | 26 | 2020 |
| 6 and 12 month outcomes in patients following COVID-19-related hospitalization: a prospective monocentric study GP Martino, D Benfaremo, G Bitti, G Valeri, L Postacchini, A Marchetti, ... Internal and Emergency Medicine 17 (6), 1641-1649, 2022 | 25 | 2022 |
Michele Maria LuchettiDipartimento Scienze Cliniche e Molecolari, Università Politecnica delle Marche, Ancona, ItalyZweryfikowany adres z univpm.it
